Trial
NCT00482274
Docetaxel in Treating Patients With Relapsed Prostate Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
National Cancer Institute (NCI)
Condition
Prostate Cancer
Intervention
docetaxel
Why stopped
Drug supplier stopped funding due to loss of study drug (docetaxel) patent.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-28